Altered neurotrophin receptor function in the developing prefrontal cortex leads to adult-onset dopaminergic hyperresponsivity and impaired prepulse inhibition of acoustic startle

Biological Psychiatry

Volumn 55, Issue 8, 2004, Pages 797-803

  Rajakumar, N ^a   Leung, L S ^a   Ma, J ^a   Rajakumar, B ^a   Rushlow, W ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Immunotoxin; Nucleus accumbens; P75 neurotrophin receptor; Schizophrenia; Sensorimotor gating; Subplate

Indexed keywords

NEUROTROPHIN RECEPTOR; SAPORIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUDITORY STIMULATION; BRAIN DEVELOPMENT; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; FEMALE; LOCOMOTION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PATHOGENESIS; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SENSORIMOTOR FUNCTION;

ACOUSTIC STIMULATION; AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; ANTIBODIES; CASPASE 3; CASPASES; CHOLINE O-ACETYLTRANSFERASE; DEXTROAMPHETAMINE; DOPAMINE; DOPAMINE AGENTS; DOSE-RESPONSE RELATIONSHIP, RADIATION; HYPERSENSITIVITY; IMMUNOHISTOCHEMISTRY; LECTINS, C-TYPE; MOTOR ACTIVITY; NERVE TISSUE PROTEINS; NEURAL INHIBITION; NEURONS; PREFRONTAL CORTEX; PROTEOCHONDROITIN SULFATES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, NERVE GROWTH FACTOR; RECEPTORS, NERVE GROWTH FACTOR; STARTLE REACTION;

EID: 1842420676     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2003.12.015     Document Type: Article

References (85)

1. Abi-Dargham A., Rodenhiser J., Printz D., Zea-Ponce Y., Gil R., Kegeles L.S., et al. Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proc Natl Acad Sci U S A. 97:2000;8104-8109.
2. Allendoerfer K.L., Cabelli R.J., Escandon E., Kaplan D.R., Nikolics K., Shatz C.J. Regulation of neurotrophin receptors during the maturation of the mammalian visual system. J Neurosci. 14:1994;1795-1811.
3. Allendoerfer K.L., Shatz C.J. The subplate, a transient neocortical structure Its role in the development of connections between thalamus and cortex. Annu Rev Neurosci. 17:1994;185-218.
4. Allendoerfer K.L., Shelton D.L., Shooter E.M., Shatz C.J. Nerve growth factor receptor immunoreactivity is transiently associated with the subplate neurons of the mammalian cerebral cortex. Proc Natl Acad Sci U S A. 87:1990;187-190.
5. Barbacid M. Structural and functional properties of the TRK family of neurotrophin receptors. Ann N Y Acad Sci. 766:1995;442-458.
6. Barde Y.A. Trophic factors and neuronal survival. Neuron. 2:1989;1525-1534.
7. Bardo M.T., Hammer R.J. Autoradiographic localization of dopamine D1 and D2 receptors in rat nucleus accumbens Resistance to differential rearing conditions. Neuroscience. 45:1991;281-290.
8. Benes F.M., Davidson J., Bird E.D. Quantitative cytoarchitectural studies of the cerebral cortex of schizophrenics. Arch Gen Psychiatry. 43:1986;31-35.
9. Benes F.M., McSparren J., Bird E.D., SanGiovanni J.P., Vincent S.L. Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Arch Gen Psychiatry. 48:1991;996-1001.
10. Benes F.M., Sorensen I., Bird E.D. Reduced neuronal size in posterior hippocampus of schizophrenic patients. Schizophr Bull. 17:1991;597-608.
11. Berardi N., Pizzorusso T., Maffei L. Critical periods during sensory development. Curr Opin Neurobiol. 10:2000;138-145.
12. Bonhoeffer T. Neurotrophins and activity-dependent development of the neocortex. Curr Opin Neurobiol. 6:1996;119-126.
13. Braff D., Stone C., Callaway E., Geyer M., Glick I., Bali L. Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology. 15:1978;339-343.
14. Braff D.L., Geyer M.A., Light G.A., Sprock J., Perry W., Cadenhead K.S., et al. Impact of prepulse characteristics on the detection of sensorimotor gating deficits in schizophrenia. Schizophr Res. 49:2001;171-178.
15. Braff D.L., Grillon C., Geyer M. Gating and habituation of the startle reflex in schizophrenic patients. Arch Gen Psychiatry. 49:1992;206-215.
16. Braff D.L., Swerdlow N.R., Geyer M.A. Symptom correlates of prepulse inhibition deficits in male schizophrenic patients. Am J Psychiatry. 156:1999;596-602.
17. Bubser M., Koch M. Prepulse inhibition of the acoustic startle response of rats is reduced by 6-hydroxydopamine lesions of the medial prefrontal cortex. Psychopharmacology. 113:1994;487-492.
18. Cabelli R.J., Shelton D.L., Segal R.A., Shatz C.J. Blockade of endogenous ligands of trkB inhibits formation of ocular dominance columns. Neuron. 19:1997;63-76.
19. Carr G.D., White N.M. Effects of systemic and intracranial amphetamine injections on behaviour in the open field A detailed analysis. Pharmcol Biochem Behav. 27:1987;113-122.
20. Cellerino A., Carroll P., Thoenen H., Barde Y.A. Reduced size of retinal ganglion cell axons and hypomyelination in mice lacking brain-derived neurotrophic factor. Mol Cell Neurosci. 9:1997;397-408.
21. Cellerino A., Maffei L. The action of neurotrophins in the development and plasticity of the visual cortex. Prog Neurobiol. 49:1996;53-71.
22. Conrad A.J., Abebe T., Austin R., Forsythe S., Scheibel A.B. Hippocampal pyramidal cell disarray in schizophrenia as a bilateral phenomenon. Arch Gen Psychiatry. 48:1991;413-417.
23. Costa E., Davis J., Grayson D.R., Guidotti A., Pappas G.D., Pesold C. Dendritic spine hypoplasticity and down regulation of reelin and GABAergic tone in schizophrenia vulnerability. Neurobiol Dis. 8:2001;723-742.
24. Das K.P., Chao S.L., White L.D., Haines W.T., Harry G.J., Tilson H.A., et al. Differential patterns of nerve growth factor, brain-derived neurotrophic factor and neurotrophin-3 mRNA and protein levels in developing regions of rat brain. Neuroscience. 103:2001;739-761.
25. Dawson M.E., Schell A.M., Hazlett E.A., Nuechterlein K.H., Fillion D.L. On the clinical and cognitive meaning of impaired sensorimotor gating in schizophrenia. Psychiatry Res. 96:2000;187-197.
26. De Carlos J.A., O'Leary D.D. Growth and targeting of subplate axons and establishment of major cortical pathways. J Neurosci. 12:1992;1194-1211.
27. DeFreitas M.F., McQuillen P.S., Shatz C.J. A novel p75NTR signaling pathway promotes survival, not death, of immunopurified neocortical subplate neurons. J Neurosci. 21:2001;5121-5129.
28. Falkai P., Bogerts B., Rozumek M. Limbic pathology in schizophrenia The entorhinal region - a morphometric study. Biol Psychiatry. 24:1988;515-521.
29. Falkai P., Bogerts B. Cell loss in the hippocampus of schizophrenics. Eur Arch Psychiatry Neurol Sci. 236:1986;154-161.
30. Fukuda T., Kawano H., Ohyama K., Li H.P., Takeda Y., Oohira A., et al. Immunohistochemical localization of neurocan and L1 in the formation of thalamocortical pathway of developing rats. J Comp Neurol. 382:1997;141-152.
31. Fukumitsu H., Furukawa Y., Tsusaka M., Kinukawa H., Nitta A., Nomoto H., et al. Simultaneous expression of brain-derived neurotrophic factor and neurotrophin-3 in Cajal-Retzius, subplate and ventricular progenitor cells during early development stages of the rat cerebral cortex. Neuroscience. 84:1998;115-127.
32. Ghosh A., Antonini A., McConnell S.K., Shatz C.J. Requirement for subplate neurons in the formation of thalamocortical connections. Nature. 347:1990;179-181.
33. Glantz L.A., Lewis D.A. Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity. Arch Gen Psychiatry. 54:1997;943-952.
34. Glantz L.A., Lewis D.A. Dendritic spine density in schizophrenia and depression. Arch Gen Psychiatry. 58:2000;203.
35. Guidotti A., Auta J., Davis J.M., Gerevini V.D., Dwivedi Y., Grayson D.R., et al. Decrease in reelin and glutamic acid decarboxylase 67 (GAD67) expression in schizophrenia and bipolar disorder. Arch Gen Psychiatry. 57:2000;1061-1069.
36. Horger B.A., Iyasere C.A., Berhow M.T., Messer C.J., Nestler E.J., Taylor J.R. Enhancement of locomotor activity and conditioned reward to cocaine by brain-derived neurotrophic factor. J Neurosci. 19:1999;4110-4122.
37. Impagnatiello F., Guidotti A.R., Pesold C., Dwivedi Y., Caruncho H., Pisu M.G., et al. A decrease of reelin expression as a putative vulnerability factor in schizophrenia. Proc Natl Acad Sci U S A. 95:1998;15718-15723.
38. Jeste D.V., Lohr J.B. Hippocampal pathologic findings in schizophrenia. A morphometric study. Arch Gen Psychiatry. 46:1989;1019-1024.
39. Jones G.H., Hernandez T.D., Kendall D.A., Marsden C.A., Robbins T.W. Dopaminergic and serotonergic function following isolation rearing in rats Study of behavioural responses and postmortem and in vivo neurochemistry. Pharmcol Biochem Behav. 43:1992;17-35.
40. Jones G.H., Marsden C.A., Robbins T.W. Increased sensitivity to amphetamine and reward-related stimuli following social isolation in rats Possible disruption of dopamine-dependent mechanisms of the nucleus accumbens. Psychopharmacology (Berl). 102:1990;364-372.
41. Kaplan D.R., Millar F.D. Neurotrophin signal transduction in the nervous system. Curr Opin Neurobiol. 10:2000;381-391.
42. Kapur S., Remington G. Dopamine D(2) receptors and their role in atypical antipsychotic action Still necessary and may even be sufficient. Biol Psychiatry. 50:2001;873-883.
43. Kapur S., Seeman P. Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics? A new hypothesis. Am J Psychiatry. 158:2001;360-369.
44. Korte M., Carroll P., Wolf E., Brem G., Thoenen H., Bonhoeffer T. Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor. Proc Natl Acad Sci U S A. 92:1995;8856-8860.
45. Kostovic I., Rakic P. Developmental history of the transient subplate zone in the visual and somatosensory cortex of the macaque monkey and human brain. J Comp Neurol. 297:1990;441-470.
46. Kovelman J.A., Scheibel A.B. A neurohistological correlate of schizophrenia. Biol Psychiatry. 19:1984;1601-1621.
47. Laruelle M., Abi-Dargham A., van Dyck C.H., Gil R., D'Souza C.D., Erdos J., et al. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc Natl Acad Sci U S A. 93:1996;9235-9240.
48. Leanza G., Nilsson O.G., Wiley R.G., Bjorklund A. Selective lesioning of the basal forebrain cholinergic system by intraventricular 192 IgG-saporin Behavioural, biochemical and stereological studies in the rat. Eur J Neurosci. 7:1995;329-343.
49. Lein E.S., Hohn A., Shatz C.J. Dynamic regulation of BDNF and NT-3 expression during visual system development. J Comp Neurol. 420:2000;1-18.
50. Le Pen G., Moreau J.-L. Disruption of prepulse inhibition of startle reflex in a neurodevelopmental model of schizophrenia Reversal by clozapine, olanzapine and risperidone but not by haloperidol. Neuropsychopharmacology. 27:2002;1-11.
51. Lewis D.A., Cruz D.A., Melchitzky D.S., Pierri J.N. Lamina-specific deficits in parvalbumin-immunoreactive varicosities in the prefrontal cortex of subjects with schizophrenia Evidence for fewer projections from the thalamus. Am J Psychiatry. 158:2001;1411-1422.
52. Lindsay R.M., Wiegand S.J., Altar C.A., DiStefano P.S. Neurotrophic factors From molecule to man. Trends Neurosci. 17:1994;182-1890.
53. Lipska B.K., Jaskiw G.E., Weinberger D.R. Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage A potential animal model of schizophrenia. Neuropsychopharmacology. 9:1993;67-75.
54. Marenco S., Weinberger D.R. The neurodevelopmental hypothesis of schizophrenia Following a trail of evidence from cradle to grave. Dev Psychopathol. 12:2000;501-527.
55. McAllister A.K., Lo D.C., Katz L.C. Neurotrophins regulate dendritic growth in developing visual cortex. Neuron. 15:1995;791-803.
56. McConnell S.K., Ghosh A., Shatz C.J. Subplate neurons pioneer the first axon pathway from the cerebral cortex. Science. 245:1989;978-982.
57. Mogenson G.J., Brudzynski S.M., Wu M., Yang C.R., Yim C.Y. From motivation to action A review of dopaminergic regulation of limbic, nucleus accumbens, ventral pallidum, pedunculopontine nuclear circuitries involved in limbic-motor integration. Kalivas P.W., Barnes C.D. Limbic Motor Circuits and Neuropsychiatry. 1993;193-236 CRC Press, Ann Arbor, MI.
58. Molnar Z., Blakemore C. How do thalamic axons find their way to the cortex? Trends Neurosci. 18:1995;389-397.
59. Nosrat C.A., Blomlof J., ElShamy W.M., Ernfors P., Olson L. Lingual deficits in BDNF and NT3 mutant mice leading to gustatory and somatosensory disturbances, respectively. Development. 124:1997;1333-1342.
60. Nicholson D.W., Ali A., Thornberry N.A., Vaillancourt J.P., Ding C.K., Gallant M., et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature. 376:(6535):1995;37-43.
61. Pakkenberg B. Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics. Arch Gen Psychiatry. 47:1990;1023-1028.
62. Pakkenberg B. Stereological quantitation of human brains from normal and schizophrenic individuals. Acta Neurol Scand Suppl. 137:1992;20-33.
63. Parwani A., Duncan E.J., Bartlett E., Madonick S.H., Efferen T.R., Rajan R., et al. Impaired prepulse inhibition of acoustic startle in schizophrenia. Biol Psychiatry. 47:2000;662-669.
64. Patapoutian A., Reichardt L.F. Trk receptors Mediators of neurotrophin action. Curr Opin Neurobiol. 11:2001;272-280.
65. Paxinos G., Ashwell K.W.S., Tork I. Atlas of the Developing Rat Nervous System. 1994;Academic Press, San Diego.
66. Pierri J.N., Volk C.L., Auh S., Sampson A., Lewis D.A. Decreased somal size of deep layer 3 pyramidal neurons in the prefrontal cortex of subjects with schizophrenia. Arch Gen Psychiatry. 58:2001;466-473.
67. Pilowsky L.S., Kerwin R.W., Murray R.M. Schizophrenia A neurodevelopmental perspective. Neuropsychopharmacology. 9:1993;83-91.
68. Pizzorusso T., Maffei L. Plasticity in the developing visual system. Curr Opin Neurol. 9:1996;122-125.
69. Rajakumar N., Laurier L., Niznik H.B., Stoessl A.J. Effects of intrastriatal infusion of D2 receptor antisense oligonucleotide on apomorphine-induced behaviours in the rat. Synapse. 26:1997;199-208.
70. Rios M., Fan G., Fekete C., Kelly J., Bates B., Kuehn R., et al. Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity. Mol Endocrinol. 15:2001;1748-1757.
71. Rylett R.J., Williams L.R. Role of neurotrophins in cholinergic-neurone function in the adult and aged CNS. Trends Neurosci. 17:1994;486-490.
72. Seeman P. Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse. 1:1987;133-152.
73. Seeman P., Kapur S. Schizophrenia More dopamine, more D2 receptors. Proc Natl Acad Sci U S A. 97:2000;7673-7675.
74. Segal R.A., Pomeroy S.L., Stiles C.D. Axonal growth and fasciculation linked to differential expression of BDNF and NT3 receptors in developing cerebellar granule cells. J Neurosci. 15:1995;4970-4981.
75. Segal R.A., Rua L., Schwartz P. Neurotrophins and programmed cell death during cerebellar development. Adv Neurol. 72:1997;79-86.
76. Selemon L.D., Goldman-Rakic P.S. The reduced neuropil hypothesis A circuit based model of schizophrenia. Biol Psychiatry. 45:1999;17-25.
77. Selemon L.D., Rajkowska G., Golman-Rakic P.S. Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17. Arch Gen Psychiatry. 52:1995;805-818.
78. Shatz C.J., Luskin M.B. The relationship between the geniculocortical afferents and their cortical target cells during development of the cat's primary visual cortex. J Neurosci. 6:1986;3655-3668.
79. Swerdlow N.R., Braff D.L., Geyer M.A. Animal models of deficient sensorimotor gating What we now, what we think we know, and what we hope to know soon. Behav Pharmacol. 11:2000;185-204.
80. Swerdlow N.R., Lipska B.K., Weinberger D.R., Braff D.L., Jaskiw G.E., Geyer M.A. Increased sensitivity to the gating disruptive effects of apomorphine after lesions of the medial prefrontal cortex or the ventral hippocampus in adult rats. Psychopharmacology. 122:1995;27-34.
81. Swerdlow N.R., Masten V., Geyer M.A., Braff D.L. Schizophrenia-like abnormalities in sensory gating following accumbens dopamine infusions in rats. Psychopharmacology. 101:1990;414-420.
82. Thome J., Foley P., Reiderer P. Neurotrophic factor and the maldevelop-mental hypothesis of schizophrenic psychoses. J Neural Transm. 105:1998;85-100.
83. von Schack D., Casademunt E., Schweigreiter R., Meyer M., Bibel M., Dechant G. Complete ablation of the neurotrophin receptor p75NTR causes defects both in the nervous and the vascular system. Nat Neurosci. 4:2001;977-978.
84. Waite J.J., Thal L.J. Lesions of the cholinergic nuclei in the rat basal forebrain Excitotoxins vs. an immunotoxin. Life Sci. 58:1996;1947-1953.
85. Weinberger D.R. From neuropathology to neurodevelopment. Lancet. 346:1995;552-557.